Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A bioresorbable collagen membrane is a specialized biomaterial used primarily in guided tissue regeneration (GTR) and guided bone regeneration (GBR) procedures within dentistry and orthopedics [1, 2]. These membranes are typically derived from highly purified Type I or Type III collagen of bovine, porcine, or equine origin [1, 5]. Their primary biological function is to act as a temporary physical barrier that prevents fast-growing epithelial and connective tissue cells from infiltrating a bone defect, thereby allowing slower-growing osteogenic cells to repopulate and regenerate the area [2, 3]. Because they are bioresorbable, they are naturally degraded by endogenous enzymes like collagenases, which eliminates the need for a second surgical procedure to remove the membrane [5, 6]. Beyond their barrier function, these membranes support wound healing by promoting platelet aggregation, stabilizing the blood clot, and providing a scaffold for cell attachment and proliferation [1, 4]. While not a traditional pharmacological target, they are frequently used as delivery vehicles for bioactive agents such as bone morphogenetic proteins (BMPs), growth factors, and antibiotics to enhance regenerative outcomes [3, 14]. Clinical success depends on the membrane's degradation rate, mechanical stability, and ability to maintain space for bone growth [2, 8]. They are widely accepted in clinical practice due to their excellent biocompatibility and low immunogenicity compared to synthetic alternatives [2, 5].
Acts as a physical barrier to exclude non-osteogenic tissues from bone defects while providing a scaffold for osteoblast migration and stabilizing the wound environment.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bioresorbable collagen membrane (BCM).